sr141716 has been researched along with Anxiety in 43 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (4.65) | 18.2507 |
| 2000's | 19 (44.19) | 29.6817 |
| 2010's | 20 (46.51) | 24.3611 |
| 2020's | 2 (4.65) | 2.80 |
| Authors | Studies |
|---|---|
| Dean, R; Hamilton, TJ; Hudson, J; Johnson, AL; Verbitsky, R | 1 |
| Cinar, R; Gao, B; Godlewski, G; Gunduz-Cinar, O; Herrerias, A; Iyer, MR; Kunos, G; Lin, Y; Santos-Molina, L; Wood, CM; Zawatsky, CN | 1 |
| Anthenelli, RM; Aubin, HJ; Cinciripini, PM; Dale, LC; Karam-Hage, M; Niaura, R; Robinson, JD | 1 |
| Genewsky, A; Heinz, DE; Wotjak, CT | 1 |
| Conger, JR; Gamble-George, JC; Gupta, P; Hartley, ND; Patel, S; Sumislawski, JJ | 1 |
| Blasio, A; Cottone, P; Di Marzo, V; Iannotti, FA; Iemolo, A; Orlando, P; Petrosino, S; Rice, KC; Sabino, V; Steardo, L; Zorrilla, EP | 1 |
| Arrais, KC; Bergamaschi, MM; Chagas, MH; Crippa, JA; de Oliveira, DC; Hallak, JE; Huestis, MA; Linares, IM; Moreira, FA; Nardi, AE; Queiroz, ME; Queiroz, RH; Zuardi, AW | 1 |
| Blasio, A; Cottone, P; Rice, KC; Sabino, V | 1 |
| Benyhe, S; Borsodi, A; Csibrány, B; Klivényi, P; Lénárt, N; Marton, A; Molnár, M; Nagy, GM; Páldy, E; Samavati, R; Sántha, M; Tuka, B; Vécsei, L; Vizler, C; Zádor, F | 1 |
| Baldaia, MA; Berro, LF; Frussa-Filho, R; Hollais, AW; Longo, BM; Marinho, EA; Oliveira-Lima, AJ; Patti, CL; Santos, R; Takatsu-Coleman, AL; Wuo-Silva, R; Yokoyama, TS | 1 |
| Campolongo, P; Cuomo, V; Hill, MN; Manduca, A; Morena, M; Palmery, M; Servadio, M; Trabace, L; Trezza, V; Vanderschuren, LJ | 1 |
| McCool, BA; McGinnis, MM; Morales, M | 1 |
| Antoniou, K; Delis, F; Gueye, AB; Laviolette, SR; Le Foll, B; Loureiro, M; Makriyannis, A; Poulia, N; Pryslawsky, Y; Trigo, JM; Vemuri, K | 1 |
| Di, S; Fisher, MO; Gilpin, NW; Itoga, CA; Roltsch, EA; Solomonow, J; Tasker, JG | 1 |
| Anderson, C; DiBerto, J; Duffy, K; Falls, WA; Fox, JH; Hammack, SE; Hardaway, JA; Hurd, YL; Kash, TL; Magness, ST; Mazzone, CM; McElligott, ZA; McKlveen, JM; Michaelides, M; Pati, D; Tipton, G | 1 |
| Hasenöhrl, RU; Ledent, C; Molleman, A; Thiemann, G; Watt, CA | 1 |
| Biala, G; Budzynska, B; Kruk, M | 1 |
| Baarendse, PJ; Trezza, V; Vanderschuren, LJ | 1 |
| Huang, P; Kirby, LG; Liu-Chen, LY | 1 |
| Hohmann, AG; Sciolino, NR; Zhou, W | 1 |
| Bialuk, I; Winnicka, MM | 1 |
| Abou-El-Ela, SH; El-Wakeil, AF; Zaitone, SA | 1 |
| Gyertyán, I; Kassai, F; Varga, B | 1 |
| Adan, RA; Meye, FJ; Ramakers, GM; Trezza, V; Vanderschuren, LJ | 1 |
| Dashney, B; Limebeer, CL; O'Brien, LD; Parker, LA; Rock, EM; Segsworth, B; Wills, KL | 1 |
| Berrendero, F; Maldonado, R | 1 |
| Bakos, N; Freund, TF; Haller, J; Ledent, C; Szirmay, M | 1 |
| Calignano, A; Cuomo, V; Duranti, A; Fegley, D; Gaetani, S; Giustino, A; Kathuria, S; La Rana, G; Mor, M; Palmery, M; Piomelli, D; Tarzia, G; Tattoli, M; Tontini, A; Valiño, F | 1 |
| Halasz, J; Haller, J; Mikics, E; Rodgers, RJ | 1 |
| Assini, FL; Ramos, GA; Takahashi, RN | 1 |
| Degroot, A; Nomikos, GG | 1 |
| Fernandes, MS; Pamplona, FA; Takahashi, RN | 1 |
| Marx, J | 1 |
| Gadde, KM | 1 |
| Ben-Shabat, S; Fride, E; Gobshtis, N | 1 |
| Kaiser, N; Lutz, B; Monory, K; Moreira, FA | 1 |
| Areda, T; Kõks, S; Raud, S; Reimets, A; Sütt, S; Vasar, E | 1 |
| Mitchell, PB; Morris, MJ | 1 |
| Al-Zaman, Y; Aylwin, S | 1 |
| de Miguel, R; Fernández-Ruiz, J; Maestro, B; Michael Walker, J; Ramos, JA; Rubio, M | 1 |
| Carrera, MR; del Arco, I; Hernández, E; Muñoz, RM; Navarro, M; Rodríguez de Fonseca, F; Villanúa, MA | 1 |
| Carrera, MR; Koob, GF; Navarro, M; Rodríguez de Fonseca, F; Weiss, F | 1 |
| Arévalo, C; de Miguel, R; Hernández-Tristán, R | 1 |
1 review(s) available for sr141716 and Anxiety
| Article | Year |
|---|---|
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
3 trial(s) available for sr141716 and Anxiety
| Article | Year |
|---|---|
Pooled analysis of three randomized, double-blind, placebo controlled trials with rimonabant for smoking cessation.
Topics: Adult; Anorexia; Anxiety; Cannabinoid Receptor Antagonists; Cigarette Smoking; Diarrhea; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Rimonabant; Smoking Cessation; Vomiting | 2018 |
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report.
Topics: Adult; Anxiety; Blood Pressure; Cannabinoid Receptor Antagonists; Double-Blind Method; Female; Heart Rate; Humans; Male; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Speech; Young Adult | 2014 |
Depression and anxiety with rimonabant.
Topics: Anti-Obesity Agents; Anxiety; Depression; Humans; Meta-Analysis as Topic; Piperidines; Pyrazoles; Rimonabant | 2007 |
39 other study(ies) available for sr141716 and Anxiety
| Article | Year |
|---|---|
Cannabinoid type-2 receptors modulate terpene induced anxiety-reduction in zebrafish.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Cannabinoids; Humans; Receptors, Cannabinoid; Rimonabant; Terpenes; Zebrafish | 2023 |
Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia.
Topics: Alcohol Drinking; Animals; Anxiety; Behavior, Animal; Cannabinoid Receptor Antagonists; Catalepsy; Cyclohexanols; Elevated Plus Maze Test; Endotoxemia; Endotoxins; Ethanol; Gastrointestinal Tract; Hypothermia, Induced; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stereoisomerism; Sulfonamides | 2021 |
Enhanced anandamide signaling reduces flight behavior elicited by an approaching robo-beetle.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Avoidance Learning; Behavior, Animal; Benzamides; Benzodioxoles; Cannabinoid Receptor Agonists; Carbamates; Diazepam; Endocannabinoids; Fear; Male; Mice, Inbred C57BL; Monoacylglycerol Lipases; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2017 |
Dissociable effects of CB1 receptor blockade on anxiety-like and consummatory behaviors in the novelty-induced hypophagia test in mice.
Topics: Animals; Anxiety; Cannabinoid Receptor Antagonists; Consummatory Behavior; Dose-Response Relationship, Drug; Feeding and Eating Disorders; Hindlimb Suspension; Male; Mice; Mice, Inbred ICR; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stress, Psychological | 2013 |
Rimonabant precipitates anxiety in rats withdrawn from palatable food: role of the central amygdala.
Topics: Amygdala; Animals; Anorexia; Anti-Obesity Agents; Anxiety; Arachidonic Acids; Body Weight; Cannabinoid Receptor Antagonists; Corticosterone; Diet; Dietary Sucrose; Endocannabinoids; Female; Glycerides; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant | 2013 |
Characterization of a shortened model of diet alternation in female rats: effects of the CB1 receptor antagonist rimonabant on food intake and anxiety-like behavior.
Topics: Animals; Anxiety; Behavior, Animal; Cannabinoid Receptor Antagonists; Dietary Sucrose; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Feeding and Eating Disorders; Female; Maze Learning; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant | 2014 |
Low dosage of rimonabant leads to anxiolytic-like behavior via inhibiting expression levels and G-protein activity of kappa opioid receptors in a cannabinoid receptor independent manner.
Topics: Adaptation, Ocular; Analgesics, Opioid; Animals; Anxiety; Cannabinoid Receptor Antagonists; CHO Cells; Cricetulus; Disease Models, Animal; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Narcotic Antagonists; Piperidines; Prosencephalon; Protein Binding; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, kappa; Rimonabant; Swimming | 2015 |
Effects of rimonabant on the development of single dose-induced behavioral sensitization to ethanol, morphine and cocaine in mice.
Topics: Akathisia, Drug-Induced; Animals; Animals, Outbred Strains; Anxiety; Cannabinoid Receptor Antagonists; Central Nervous System Depressants; Cocaine; Depression; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Ethanol; Male; Mice; Morphine; Motor Activity; Narcotics; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance-Related Disorders | 2015 |
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats.
Topics: Aging; Animals; Anxiety; Arachidonic Acids; Brain; Cannabinoid Receptor Modulators; Carbamates; Endocannabinoids; Exploratory Behavior; Glycerides; Male; Piperazines; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Rats, Sprague-Dawley; Rimonabant; Social Behavior | 2015 |
Chronic ethanol exposure increases voluntary home cage intake in adult male, but not female, Long-Evans rats.
Topics: Alcohol Drinking; Animals; Anxiety; Choice Behavior; Dose-Response Relationship, Drug; Drinking; Ethanol; Female; Male; Maze Learning; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Sex Characteristics | 2015 |
The CB1 Neutral Antagonist AM4113 Retains the Therapeutic Efficacy of the Inverse Agonist Rimonabant for Nicotine Dependence and Weight Loss with Better Psychiatric Tolerability.
Topics: Animals; Anxiety; Behavior, Addictive; Behavior, Animal; Cannabinoid Receptor Antagonists; Cues; Depression; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Drug Inverse Agonism; Drug-Seeking Behavior; Male; Maze Learning; Mesencephalon; Motivation; Motor Activity; Piperidines; Pyrazoles; Rats, Long-Evans; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction; Swimming; Time Factors; Tobacco Use Cessation Devices; Tobacco Use Disorder; Weight Loss | 2016 |
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala.
Topics: Animals; Antiemetics; Anxiety; Arachidonic Acids; Basolateral Nuclear Complex; Benzoxazines; Calcium Channel Blockers; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Dexamethasone; Disease Models, Animal; Endocannabinoids; Enzyme Inhibitors; Glucocorticoids; Glycerides; Inhibitory Postsynaptic Potentials; Male; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Restraint, Physical; Rimonabant; Synaptic Transmission | 2016 |
Acute engagement of G
Topics: Animals; Anti-Anxiety Agents; Anxiety; Brain Mapping; Cannabinoid Receptor Antagonists; Clozapine; Dark Adaptation; Disease Models, Animal; Estrenes; Excitatory Postsynaptic Potentials; Exploratory Behavior; Green Fluorescent Proteins; GTP-Binding Protein alpha Subunits, Gq-G11; In Vitro Techniques; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neurons; Phosphodiesterase Inhibitors; Piperazines; Pyrrolidinones; Receptors, Drug; Rimonabant; RNA, Messenger; Septal Nuclei; Serotonin Receptor Agonists; Signal Transduction; Sodium Channel Blockers; Tetrodotoxin; Vesicular Inhibitory Amino Acid Transport Proteins | 2018 |
Modulation of anxiety by acute blockade and genetic deletion of the CB(1) cannabinoid receptor in mice together with biogenic amine changes in the forebrain.
Topics: Analysis of Variance; Animals; Anxiety; Behavior, Animal; Biogenic Amines; Brain Chemistry; Disease Models, Animal; Dose-Response Relationship, Drug; Exploratory Behavior; Locomotion; Male; Maze Learning; Mice; Mice, Knockout; Piperidines; Prosencephalon; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Statistics as Topic | 2009 |
Effects of the cannabinoid receptor ligands on anxiety-related effects of d-amphetamine and nicotine in the mouse elevated plus maze test.
Topics: Animals; Anxiety; Benzoxazines; Cannabinoid Receptor Agonists; Central Nervous System Stimulants; Dextroamphetamine; Dose-Response Relationship, Drug; Drug Interactions; Ligands; Male; Maze Learning; Mice; Morpholines; Naphthalenes; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Cannabinoid; Rimonabant | 2009 |
Prosocial effects of nicotine and ethanol in adolescent rats through partially dissociable neurobehavioral mechanisms.
Topics: Aging; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Central Nervous System Depressants; Diazepam; Dopamine Antagonists; Ethanol; Exploratory Behavior; Flupenthixol; Locomotion; Male; Naloxone; Narcotic Antagonists; Nicotine; Nicotinic Agonists; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Social Behavior | 2009 |
Anxiety-like effects of SR141716-precipitated delta9-tetrahydrocannabinol withdrawal in mice in the elevated plus-maze.
Topics: Animals; Anxiety; Dronabinol; Emotions; Male; Maze Learning; Mice; Mice, Inbred ICR; Piperidines; Psychotropic Drugs; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Substance Withdrawal Syndrome | 2010 |
Enhancement of endocannabinoid signaling with JZL184, an inhibitor of the 2-arachidonoylglycerol hydrolyzing enzyme monoacylglycerol lipase, produces anxiolytic effects under conditions of high environmental aversiveness in rats.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzodioxoles; Cannabinoid Receptor Modulators; Catalepsy; Diazepam; Endocannabinoids; Glycerides; Male; Monoacylglycerol Lipases; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant; Signal Transduction | 2011 |
AM251, cannabinoids receptors ligand, improves recognition memory in rats.
Topics: Animals; Anxiety; Dose-Response Relationship, Drug; Male; Maze Learning; Motor Activity; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Recognition, Psychology; Rimonabant | 2011 |
Inhibition of fatty acid amide hydrolase by URB597 attenuates the anxiolytic-like effect of acetaminophen in the mouse elevated plus-maze test.
Topics: Acetaminophen; Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Benzamides; Carbamates; Disease Models, Animal; Dose-Response Relationship, Drug; Injections, Intraperitoneal; Male; Maze Learning; Mice; Mice, Inbred BALB C; Motor Activity; Piperidines; Pyrazoles; Rimonabant | 2012 |
Interactions of CB1 and mGlu5 receptor antagonists in food intake, anxiety and memory models in rats.
Topics: Animals; Anxiety; Disease Models, Animal; Fear; Feeding Behavior; Male; Memory; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Rimonabant; Thiazoles | 2012 |
Neutral antagonism at the cannabinoid 1 receptor: a safer treatment for obesity.
Topics: Amygdala; Animals; Anxiety; Dopaminergic Neurons; Eating; GABAergic Neurons; Humans; Male; Mice; Mice, Inbred C57BL; Obesity; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Ventral Tegmental Area; Weight Gain | 2013 |
Effect of chronic exposure to rimonabant and phytocannabinoids on anxiety-like behavior and saccharin palatability.
Topics: Animals; Anxiety; Behavior, Animal; Cannabidiol; Cannabinoid Receptor Antagonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Administration Schedule; Drug Inverse Agonism; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Rimonabant; Saccharin; Taste; Taste Perception | 2013 |
Involvement of the opioid system in the anxiolytic-like effects induced by Delta(9)-tetrahydrocannabinol.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Darkness; Dronabinol; Endorphins; Light; Male; Mice; Naltrexone; Narcotic Antagonists; Piperidines; Pyrazoles; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Rimonabant | 2002 |
The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety.
Topics: Animals; Anxiety; Exploratory Behavior; Maze Learning; Mice; Mice, Knockout; Motor Activity; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2002 |
Modulation of anxiety through blockade of anandamide hydrolysis.
Topics: Amidohydrolases; Animals; Anti-Anxiety Agents; Anxiety; Arachidonic Acids; Behavior, Animal; Cannabinoids; Cells, Cultured; Dose-Response Relationship, Drug; Endocannabinoids; Humans; Molecular Structure; Neurons; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Radioligand Assay; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Vocalization, Animal | 2003 |
'One-trial sensitization' to the anxiolytic-like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus-maze.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Cannabinoid Receptor Modulators; Chlordiazepoxide; Male; Maze Learning; Mice; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2003 |
Anxiety does not affect the antinociceptive effect of Delta 9-THC in mice: participation of cannabinoid and opioid receptors.
Topics: Animals; Anxiety; Cannabinoid Receptor Antagonists; Dose-Response Relationship, Drug; Dronabinol; Male; Mice; Naloxone; Narcotic Antagonists; Pain Measurement; Piperidines; Pyrazoles; Receptors, Cannabinoid; Receptors, Opioid; Rimonabant | 2003 |
Genetic deletion and pharmacological blockade of CB1 receptors modulates anxiety in the shock-probe burying test.
Topics: Animals; Anxiety; Carbolines; Chlordiazepoxide; Electroshock; Gene Deletion; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2004 |
The cannabinoid antagonist SR141716A facilitates memory acquisition and consolidation in the mouse elevated T-maze.
Topics: Animals; Anxiety; Cannabinoid Receptor Modulators; Drug Interactions; Hippocampus; Male; Maze Learning; Memory; Memory Disorders; Mice; Motor Activity; Muscarinic Antagonists; Neural Pathways; Neurons; Nootropic Agents; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Scopolamine | 2005 |
Drug development. Drugs inspired by a drug.
Topics: Animals; Anti-Obesity Agents; Anxiety; Arachidonic Acids; Blood Pressure; Brain; Cannabinoid Receptor Antagonists; Cannabinoid Receptor Modulators; Controlled Clinical Trials as Topic; Drug Evaluation, Preclinical; Endocannabinoids; Humans; Inflammation; Neurons; Obesity; Osteoporosis; Pain; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptors, Cannabinoid; Rimonabant; Smoking Cessation | 2006 |
Effect of rimonabant on weight and cardiometabolic risk factors.
Topics: Anti-Obesity Agents; Anxiety; Depression; Humans; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Risk Factors | 2006 |
Antidepressant-induced undesirable weight gain: prevention with rimonabant without interference with behavioral effectiveness.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Desipramine; Female; Fluoxetine; Maze Learning; Mice; Motor Activity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Swimming; Time Factors; Weight Gain | 2007 |
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
Topics: Amidohydrolases; Analysis of Variance; Animals; Anxiety; Arachidonic Acids; Behavior, Animal; Benzamides; Carbamates; Disease Models, Animal; Endocannabinoids; Glycerides; Male; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Knockout; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant | 2008 |
Cat odour-induced anxiety--a study of the involvement of the endocannabinoid system.
Topics: Amidohydrolases; Amygdala; Animals; Anxiety; Cannabinoid Receptor Modulators; Cats; DNA, Complementary; Endocannabinoids; Exploratory Behavior; Limbic System; Male; Motor Activity; Odorants; Periaqueductal Gray; Phospholipase D; Piperidines; Predatory Behavior; Pyrazoles; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; Rimonabant; RNA | 2008 |
CB1 receptor blockade reduces the anxiogenic-like response and ameliorates the neurochemical imbalances associated with alcohol withdrawal in rats.
Topics: Animals; Anxiety; Appetite; Arachidonic Acids; Autoradiography; Benzoxazines; Brain Chemistry; Cannabinoid Receptor Modulators; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Emotions; Endocannabinoids; Enkephalins; Ethanol; Ethanolamines; Glycerides; In Situ Hybridization; Male; Morpholines; Motor Activity; Naphthalenes; Neuropeptide Y; Neurotransmitter Agents; Piperidines; Polyunsaturated Alkamides; Protein Precursors; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; RNA, Messenger; Stress, Psychological; Substance Withdrawal Syndrome | 2008 |
Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat.
Topics: Animals; Anxiety; Behavior, Animal; Dose-Response Relationship, Drug; Male; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Time Factors | 1997 |
Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal.
Topics: Amygdala; Animals; Anxiety; Behavior, Animal; Brain; Corticosterone; Corticotropin-Releasing Hormone; Dronabinol; Male; Microdialysis; Piperidines; Proto-Oncogene Proteins c-fos; Pyrazoles; Rats; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Substance Withdrawal Syndrome | 1997 |
Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters.
Topics: Analgesics; Animals; Anxiety; Cannabinoids; Cyclohexanols; Drug Therapy, Combination; Exploratory Behavior; Hypothalamus; Male; Motor Activity; Neurotransmitter Agents; Piperidines; Pyrazoles; Rats; Rats, Wistar; Rimonabant | 2001 |